Alpha Biopharma Stock

Alpha Biophama is a clinical stage biopharmaceutical company.

Sign up today and learn more about Alpha Biopharma Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Alpha Biopharma Stock

Alpha Biopharma is supported by the domestic and foreign famous funds, and committed to the clinical development of global innovator drug. The company collaborates with the large-scale international drug companies to ensure the preliminary research and development of the product is solid and reliable. By using the powerful scientific consultant and management team and developing the optimization strategy for innovative drug development, the company lay emphasis on the multi-dimensional layout: research and development/market/intellectual property protection. The specifictest operation and business development are collaborated with the international/domestic topCRO/CMO/hospital/institute, and ensure the program is rational and orderly implementation by using the company’s impeccable project management system.

Funding History

June 2018$37.0M
April 2021$25.0M



Liu Zhonghai

Chief Operational Officer

James Liu

Board Of Directors

William Hu


Joan CAI

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: